Patella V 1

1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
2. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
3. Management of anaphylaxis due to COVID-19 vaccines in the elderly
4. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
5. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
6. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
7. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
8. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air^® real-world data
9. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
10. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
1